+

DK200801818A - Vaccine antigens from piscirickettsia salmonis - Google Patents

Vaccine antigens from piscirickettsia salmonis Download PDF

Info

Publication number
DK200801818A
DK200801818A DK200801818A DKPA200801818A DK200801818A DK 200801818 A DK200801818 A DK 200801818A DK 200801818 A DK200801818 A DK 200801818A DK PA200801818 A DKPA200801818 A DK PA200801818A DK 200801818 A DK200801818 A DK 200801818A
Authority
DK
Denmark
Prior art keywords
protein
seq
amino acid
vaccine
group
Prior art date
Application number
DK200801818A
Other languages
English (en)
Inventor
Kirke David Francis
Francis Michael James
Original Assignee
Schering Plough Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Plough Ltd filed Critical Schering Plough Ltd
Publication of DK200801818A publication Critical patent/DK200801818A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0233—Rickettsiales, e.g. Anaplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1246—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Rickettsiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK200801818A 2007-12-19 2008-12-19 Vaccine antigens from piscirickettsia salmonis DK200801818A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1478207P 2007-12-19 2007-12-19
US1478207 2007-12-19

Publications (1)

Publication Number Publication Date
DK200801818A true DK200801818A (da) 2009-06-20

Family

ID=40471541

Family Applications (1)

Application Number Title Priority Date Filing Date
DK200801818A DK200801818A (da) 2007-12-19 2008-12-19 Vaccine antigens from piscirickettsia salmonis

Country Status (6)

Country Link
US (2) US7811583B2 (da)
EP (1) EP2231698B9 (da)
AU (1) AU2008337440B2 (da)
CA (1) CA2708167C (da)
DK (1) DK200801818A (da)
WO (1) WO2009077577A2 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1523330T3 (da) * 2002-07-15 2009-11-23 Novartis Ag Vaccine mod laksefisk-rickettsial septicæmi baseret på Arthrobacter-celler
EP2950816B1 (en) 2013-02-04 2019-07-31 Schweitzer Biotech Company Ltd. The use of dna sequences encoding an interferon as vaccine adjuvants
CN103110583A (zh) * 2013-03-05 2013-05-22 西南民族大学 一种绵羊肺炎支原体灭活疫苗的制备工艺
CA2915211C (en) * 2013-06-14 2022-08-23 Cermaq As Novel piscirickettsia salmonis isolate
US9580758B2 (en) 2013-11-12 2017-02-28 Luc Montagnier System and method for the detection and treatment of infection by a microbial agent associated with HIV infection
EP3249041A1 (en) * 2014-11-24 2017-11-29 Pontificia Universidad Católica De Valparaíso Culture medium allowing the growth of the bacterium piscirickettsia salmonis
CL2017003358A1 (es) * 2017-12-26 2018-06-22 Univ De Chile 50% Formulación de vacuna para peces en base a nanovesículas lipídicas, en especial, un proteoliposoma o cocleato, con actividad contra el síndrome rickettsial del salmón
WO2021247715A2 (en) * 2020-06-03 2021-12-09 The Regents Of The University Of California Immunogenic francisella antigens and their use in immunization of fish against francisellosis
CN117625557B (zh) * 2023-11-23 2024-09-27 中国水产科学研究院珠江水产研究所 一株大口黑鲈（Micropterus salmoides）蛙虹彩病毒（Ranavirus sp.）及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5165925A (en) 1989-05-02 1992-11-24 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Vaccine for immunizing fish against infectious pancreatic necrosis virus
DE69531891D1 (de) 1994-10-18 2003-11-13 Akzo Nobel Nv Virus, welches die Pankreas-Krankheit bei Fischen verursacht
NO329958B1 (no) 1999-09-17 2011-01-31 Pfizer Canada Inc Anvendelse av en immunogen mengde av OspA-lipoprotein fra Piscirickettsia salmonis, OspA-antigen, og immunogene promiskuose TCE i et OspA-kimaert fusjonsprotein, for fremstilling av medikamenter, og immunologisk in vitro-fremgangsmate for deteksjon av humoralt antistoff mot OspA eller P. salmonis.
US20030165526A1 (en) 1999-09-17 2003-09-04 Kuzyk Michael A. Vaccines and agents for inducing immunity against rickettsial diseases, and associated preventative therapy
WO2001049712A2 (en) 2000-01-07 2001-07-12 Akzo Nobel N.V. Vaccine against isav (infectious salmon anaemia virus)
WO2001068865A2 (en) 2000-03-11 2001-09-20 Novartis Ag Fish vaccine against piscirickettsia salmonis
US6863892B2 (en) 2000-08-22 2005-03-08 Agensys, Inc. Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
WO2002038770A1 (en) 2000-11-11 2002-05-16 The University Court Of The University Of Aberdeen Yeast derived vaccine against ipnv
CA2457349A1 (en) 2001-08-10 2003-02-20 University Of Maryland Biotechnology Institute Sub-unit vaccine for infectious pancreatic necrosis virus
CA2381708C (en) 2001-08-27 2011-10-18 Universidad Catolica De Valparaiso Immunogenic protein against piscirickettsia salmonis
DK1523330T3 (da) 2002-07-15 2009-11-23 Novartis Ag Vaccine mod laksefisk-rickettsial septicæmi baseret på Arthrobacter-celler
EP1670818B1 (en) 2003-10-07 2010-07-07 Michel Thiry Piscirickettsia salmonis antigens and use thereof
AU2005291622A1 (en) 2004-10-01 2006-04-13 Michel Thiry Piscirickettsia salmonis antigens and use thereof

Also Published As

Publication number Publication date
US20110070256A1 (en) 2011-03-24
CA2708167A1 (en) 2009-06-25
WO2009077577A3 (en) 2009-09-24
CA2708167C (en) 2016-11-29
US20090162391A1 (en) 2009-06-25
AU2008337440B2 (en) 2013-05-02
WO2009077577A2 (en) 2009-06-25
US7811583B2 (en) 2010-10-12
EP2231698A2 (en) 2010-09-29
AU2008337440A1 (en) 2009-06-25
EP2231698B1 (en) 2014-07-30
EP2231698B9 (en) 2014-10-29

Similar Documents

Publication Publication Date Title
DK200801818A (da) Vaccine antigens from piscirickettsia salmonis
DK179920B1 (da) Nucleic acid sequences of a fish virus and the use thereof
Meir et al. Immune responses to mucosal vaccination by the recombinant S1 and N proteins of infectious bronchitis virus
CN109867727B (zh) 一种flagellin-fiber2融合蛋白、其制备方法和应用
CN107529534A (zh) 一种副鸡禽杆菌的保护性抗原、及其表达和应用
US20150306209A1 (en) CANINE PARVOVIRUS TYPE 2c ISOLATES AND METHODS OF USE
DK202170230A1 (en) Fish virus
WO2009056541A1 (en) Protection of an animal against pestivirus infection
US20250057946A1 (en) Use of interferon as an adjuvant in vaccines
Zhou et al. A novel multivalent vaccine based on secretary antigen-delivery induces protective immunity against Vibrio anguillarum and Aeromonas hydrophila
CN101880647A (zh) 重组猪霍乱沙门氏菌及二价基因工程疫苗与应用
CN104119441B (zh) 牛a型口蹄疫广谱多表位疫苗及其制备方法和应用
DK202470172A1 (en) Compositions and methods for prevention of piscine myocarditis
CN108822192A (zh) 一种胸膜肺炎放线杆菌免疫保护性抗原蛋白apjl_1976及其应用
KR101765394B1 (ko) 돼지 유행성설사 바이러스의 에피토프 단백질, 이를 암호화하는 유전자를 포함하는 재조합 벡터, 이를 발현하는 형질전환체 및 이를 포함하는 돼지 유행성설사 바이러스 예방 또는 치료용 조성물
CN107625960A (zh) 一种通用型猪大肠杆菌病疫苗及其制备方法
CN108840913A (zh) 一种胸膜肺炎放线杆菌免疫保护性抗原蛋白apjl_0922及其应用
DK200900603A (da) Piscirickettsia salmonis-antigener og anvendelse deraf
KR102451412B1 (ko) 세포성, 체액성 면역 반응의 동시 유도 및 광범위한 방어능을 갖는 신규 면역 증강용 단백질 및 이를 포함하는 구제역 백신 조성물
Yuan et al. Antibody study in canine distemper virus nucleocapsid protein gene-immunized mice
RU2707129C2 (ru) СПОСОБ ПОЛУЧЕНИЯ ШТАММА Е. coli BL21 Star™(DE3) pET302/NT-His tcpA - ПРОДУЦЕНТА РЕКОМБИНАНТНОГО БЕЛКА Тср А ХОЛЕРНОГО ВИБРИОНА БИОВАРА ЭЛЬ ТОР
DK200700656A (da) Piscirickettsia salmonis-antigener og anvendelse deraf
CN107245105B (zh) HN-VP233-221aa融合蛋白及其制备方法和应用
CN104357458A (zh) 一种重组副猪嗜血杆菌免疫保护性抗原PotD及其制备方法
US20250057937A1 (en) Compositions and methods for expressing antigens on cell membrane

Legal Events

Date Code Title Description
PHB Application deemed withdrawn due to non-payment or other reasons

Effective date: 20140624

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载